Sep 8, 2011

Research into the effectiveness of Zirtek in children younger than 3 years

The purpose of this study was to assess the Compliance Department and tolerance while taking cetirizine in children aged under 3 years of age suffering from atopic dermatitis and other allergic diseases. Under the on-compliance was 64 children. Mean age was 17 months (range 7-34 months).

The surveyed children suffered from allergic diseases following: atopic dermatitis, urticaria, rhinoconjunctivitis, atopic dermatitis associated with bronchial asthma, bronchial asthma, anaphylaxis to cow's milk.

(Zirtek) was administered in the form of a drop rate of 0.4 mg / kg for 2 months. Children with atopic dermatitis received a standard diet hypoallergenic. If necessary, erythromycin was administered.

In evaluating the clinical manifestations of disease after 2 months of treatment showed complete disappearance of the symptoms of urticaria and a significant reduction of clinical manifestations of atopic dermatitis (p <0,001). Any side effects while taking cetirizine wasn't observed.

No comments: